These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18602434)

  • 1. European Sero-Epidemiology Network 2: standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations.
    Giammanco A; Nardone A; Pebody R; Kafatos G; Andrews N; Chiarini A; Taormina S; de Ory F; Prosenc K; Krize B; Hallander H; Ljungman M; Marva E; Tsakris A; O'Flanagan D; Schneider F; Griskevicius A; Vranckx R; Karacs I
    Vaccine; 2008 Aug; 26(35):4486-93. PubMed ID: 18602434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EUVAC.NET collaborative study: evaluation and standardisation of serology for diagnosis of pertussis.
    Xing D; Markey K; Newland P; Rigsby P; Hockley J; He Q
    J Immunol Methods; 2011 Sep; 372(1-2):137-45. PubMed ID: 21782823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
    Prince HE; Lapé-Nixon M; Matud J
    Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Sero-Epidemiology Network: standardisation of the assay results for pertussis.
    Giammanco A; Chiarini A; Maple PA; Andrews N; Pebody R; Gay N; Olander RM; Fivet-Groyne F; Baron S; Tischer A; Swidsinski S; Schellekens J; Reizenstein E
    Vaccine; 2003 Dec; 22(1):112-20. PubMed ID: 14604578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pertussis seroprevalence and vaccination status in three selected provinces of Turkey].
    Kurtoğlu D; Gözalan A; Cöplü N; Miyamura K; Ishida S; Morita M; Akin L; Esen B
    Mikrobiyol Bul; 2008 Jul; 42(3):389-98. PubMed ID: 18822881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of serum anti-Bordetella pertussis antibody titers among medical staff members.
    Higa F; Haranaga S; Tateyama M; Hibiya K; Yamashiro T; Nakamatsu M; Tomoyose T; Nagahama M; Okamura T; Owan T; Kuda T; Kinjo F; Fujita J
    Jpn J Infect Dis; 2008 Sep; 61(5):371-4. PubMed ID: 18806344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children.
    Hallander HO; Ljungman M; Storsaeter J; Gustafsson L
    APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis serological potency test as an alternatively to the intracerebral mouse protection test.
    van der Ark A; van Straaten-van de Kappelle I; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():271-81. PubMed ID: 8785956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pertussis Serological Potency Test. Collaborative study to evaluatereplacement of the Mouse Protection Test.
    van der Ark A; van Straaten-van de Kappelle I; Olander RM; Enssle K; Jadhav S; van de Donk H; Hendriksen C
    Biologicals; 2000 Jun; 28(2):105-18. PubMed ID: 10885617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
    Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
    Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
    Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
    Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of Ph. Eur. Bordetella pertussis mouse antiserum Biological Reference Preparation batches 2, 3 and 4.
    Morgeaux S; Chagnaud P; Variot P; Le Tallec D; Behr-Gross ME
    Pharmeur Bio Sci Notes; 2020; 2020():161-202. PubMed ID: 32788038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterisation of a candidate hyper-immune serum for the replacement of the Bordetella pertussis mouse antiserum Biological Reference Preparation.
    Morgeaux S; Bornstein N; Mourton-Gilles C; Chagnaud P; Charbonneau J; Maurin J; Daas A; Variot P; Behr-Gross ME
    Pharmeur Bio Sci Notes; 2020; 2020():141-160. PubMed ID: 32788037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.
    Riffelmann M; Thiel K; Schmetz J; Wirsing von Koenig CH
    J Clin Microbiol; 2010 Dec; 48(12):4459-63. PubMed ID: 20943873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.
    Le T; Cherry JD; Chang SJ; Knoll MD; Lee ML; Barenkamp S; Bernstein D; Edelman R; Edwards KM; Greenberg D; Keitel W; Treanor J; Ward JI;
    J Infect Dis; 2004 Aug; 190(3):535-44. PubMed ID: 15243929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of commercial serological assays measuring Bordetella pertussis IgG antibodies.
    Fedele G; Leone P; Bellino S; Schiavoni I; Pavia C; Lazzarotto T; Stefanelli P
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):157-162. PubMed ID: 29221733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
    APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixture model analysis for establishing a diagnostic cut-off point for pertussis antibody levels.
    Baughman AL; Bisgard KM; Lynn F; Meade BD
    Stat Med; 2006 Sep; 25(17):2994-3010. PubMed ID: 16345022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults.
    Diez-Domingo J; Ballester A; Baldó JM; Planelles MV; Villarroya JV; Alvarez T; Carmen Peidró M; Calero P; Garcés MD; Sorribes I; Graullera M; Jubert A; San-Martín M; González A
    J Infect; 2004 Oct; 49(3):242-7. PubMed ID: 15337342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Standardization of an in-house ELISA for pertussis serology and its application in a seroepidemiological study].
    Cöplü N; Esen B; Kurtoğlu D; Gözalan A; Miyamura K; Yoshida I
    Mikrobiyol Bul; 2005 Jul; 39(3):281-9. PubMed ID: 16358487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.